共 142 条
[11]
Kosaka K(2001)The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials Ann Intern Med. 134 657-40
[12]
Fujiwara H(2015)Ultrasound guided aspiration of hydrosalpinx fluid versus salpingectomy in the management of patients with ultrasound visible hydrosalpinx undergoing IVF-ET: a randomized controlled trial BMC Womens Health. 15 177-93
[13]
Tatsumi K(1989)Ovarian hyperstimulation syndrome: an update review Obstet. Gynecol. Surv. 44 430-11
[14]
Yoshioka S(1999)Serum vascular endothelium growth factor concentrations in in vitro fertilization cycles predict the risk of ovarian hyperstimulation syndrome Fertil Steril 71 287-72
[15]
Sato Y(2011)Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome Cochrane Database Syst Rev. 15 CD002811-80
[16]
Egawa H(1993)Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer Obstet Gynecol. 81 1009-53
[17]
Kosaka K(2005)Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome Hum Reprod. 20 3167-72
[18]
Fujiwara H(2006)The optimal length of ‘coasting protocol’ in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization Hum Fertil (Camb) 9 175-41
[19]
Yoshioka S(2003)Multi-factorial role of GnRH-I and GnRH-II in the human ovary Mol Cell Endocrinol. 202 145-8
[20]
Fujii S(2003)Differential regulation of gonadotropin releasing hormone (GnRH)I and GnRHII messenger ribonucleic acid by gonadal steroids in human granulosa luteal cells J Clin Endocrinol Metab. 88 663-91